If you or a loved one have taken (or affected by) Invokana after March 2013 please contact us today.

Invokana Linked to Potentially Fatal Ketoacidosis

Type 2 diabetes patients who are taking Invokana to control blood sugar levels could be at risk for developing a serious condition known as ketoacidosis that can lead to brain swelling, coma and even death. If you are currently taking this drug, read on to find out more about the potential dangers and side effects of this medication. You could be entitled to compensation for any injuries you’ve suffered.

What is Invokana?

Manufactured by Janssen Pharmaceuticals and released in March 2013, Invokana is an oral medication prescribed to reduce blood sugar in patients with Type 2 diabetes. As the first SGLT2 inhibitor approved by the FDA, Invokana works by blocking the reabsorption of glucose in the kidneys and increasing glucose secretion. Excess blood sugar is expelled through urination.

What are the risks?

The FDA warns that patients taking Invokana are at risk for developing a serious condition known as ketoacidosis, that can cause severe dehydration, dangerous brain swelling, coma and death. Ketoacidosis occurs when sugar cannot be used as a fuel source in the body due to too little or no insulin. As the body breaks down fat to use as an alternative fuel source, it produces a waste product called ketones. As ketones build up in the bloodstream, they become toxic to the body. This condition is an emergency and can lead to death if not treated promptly. Common warning signs of ketoacidosis include abdominal pain, confusion, unexplained fatigue, dehydration, and vomiting.



Invokana has also been linked to an increased risk of urinary tract infections, serious blood infections and kidney injury. An increased risk for cardiovascular problems including stroke, blood clots and heart attacks was also noted in a clinical trial that the FDA required Johnson & Johnson to conduct.

The FDA ordered all manufacturers of SGLT2 inhibitors to update drug labeling to include a warning for the risk of ketoacidosis and urinary tract infections in December of 2015.

Invokana Lawsuits

Attorneys have begun filing Invokana lawsuits on behalf of patients who have suffered from ketoacidosis after taking Invokana. Lawsuits have also been filed against other drug companies who manufacture similar SGLT2 inhibitors, including Invokamet, Xigduo XR and Jardiance. Each Invokana lawsuit alleges that the drug’s manufacturer failed to warn consumers about the risks for kidney failure, heart attacks and ketoacidosis associated with the medication.

What You Can Do Now

If you or a loved one has suffered from diabetic ketoacidosis, kidney failure, coma, stroke, heart attack or cardiomyopathy as a result of taking Invokana, we can help you find the right attorney to handle your Invokana lawsuit.

Helping the Injured has been helping consumers find credible law firms that handle specific case areas for over 25 years. The Invokana injury attorneys we work with have a documented track record in understanding these drugs and the injuries associated with them. These attorneys work on a contingency basis, so there’s no cost to you!


Regardless of where you were administered Invokana our Invokana lawsuit lawyers can help as they serve all 50 states and Washington D.C. including: Alabama, Alaska, Arkansas, California, Colorado, Connecticut, Delaware, Florida, Georgia, Hawaii, Idaho, Illinois, Indiana, Iowa, Kansas, Kentucky, Louisiana, Maine, Maryland, Massachusetts, Michigan, Minnesota, Mississippi, Missouri, Montana, Nebraska, Nevada, New Hampshire, New Jersey, New Mexico, New York, North Carolina, North Dakota, Ohio, Oklahoma, Oregon, Pennsylvania, Rhode Island, South Carolina, South Dakota, Tennessee, Texas, Utah, Vermont, Virginia, Washington, Washington D.C., West Virginia and Wisconsin.

Review My Case